Dr. Bobbie J. Rimel

Dr. Bobbie J. Rimel, MD, is a widely regarded gynecologic oncologist at Cedars‑Sinai Medical Center, where she also serves as Medical Director of the Cancer Clinical Trials Office. She earned her medical degree from Duke University School of Medicine, completed her Obstetrics & Gynecology residency at Northwestern University’s McGaw Medical Center, and finished fellowship training in Gynecologic Oncology at Washington University in St. Louis. In addition to her clinical practice, she holds the rank of Associate Professor and plays an active role in overseeing tumor board reviews. She provides comprehensive care for patients with ovarian, uterine, cervical, and other gynecologic cancers—seen in both in-person and telehealth formats—demonstrating a commitment to accessible, patient-centered oncology services.

She is widely recognized for her leadership in clinical trial design, recruitment strategies, and efforts to reduce enrollment barriers in oncology research. Dr. Rimel led the development of Cedars‑Sinai’s first patient-facing online registry for women interested in clinical trial participation, earning national accolades for advancing informed consent processes and registry accessibility. Under her guidance, the Cancer Clinical Trials Office integrated digital tools to streamline cohort identification and improve research visibility. She has also played a significant role in major Phase III studies, including the NOVA trial in platinum-resistant ovarian cancer, helping advance novel therapeutics and study methodologies. Her expertise supports both pioneering research and practical applications in oncology care delivery.

In addition to her research contributions, Dr. Rimel demonstrates unwavering dedication to education and equitable cancer care. She mentors medical students, residents, and fellows in clinical and academic oncology settings. Her influence extends to institutional policies, where she shapes tumor board discussions, co-directs efforts around trial transparency, and leads protocol review initiatives. She also lectures at conferences and participates in committees that address clinical trial accessibility and informed consent standards. Through her combined roles in leadership, innovation, clinical care, and mentorship, Dr. Rimel is recognized as a leading expert in gynecologic oncology and cancer clinical trials.